中文

Edwards Lifesciences Corp Revenue Breakdown

Period 2026-06-30 (quarterly)
ItemAmountY/Y
Revenue$1.74B+13.6%
Gross profit$1.35B
Operating income$0.51B
Net income$0.24B-27.2%
Gross margin77.5%Net margin 13.9%
Revenue Q/Q+5.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$0.39B22.5%
R&D$0.28B16.0%
SG&A$0.56B32.2%
Tax & other$0.27B15.6%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

EAELVEMEEMRETREOGEQTEFXEQIXEQRERIEESS

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies